-
" Deutsche Bank pharmaceuticals analyst Barbara Ryan says the impact of SEAS on Vytorin sales has been "negligible.
FORBES: Magazine Article
-
"This was as good as it could get, " says Barbara Ryan at Deutsche Bank, noting that Pfizer won on both patents.
FORBES: Magazine Article
-
"There was still supposed to be some inventory work-off in the first quarter, " says Barbara Ryan, an analyst at Deutsche Bank.
FORBES: More Promises From Bristol-Myers